AU2019100469A4 - Methods and compositions for visibly whitening teeth without peroxide - Google Patents
Methods and compositions for visibly whitening teeth without peroxide Download PDFInfo
- Publication number
- AU2019100469A4 AU2019100469A4 AU2019100469A AU2019100469A AU2019100469A4 AU 2019100469 A4 AU2019100469 A4 AU 2019100469A4 AU 2019100469 A AU2019100469 A AU 2019100469A AU 2019100469 A AU2019100469 A AU 2019100469A AU 2019100469 A4 AU2019100469 A4 AU 2019100469A4
- Authority
- AU
- Australia
- Prior art keywords
- whitening
- oil
- teeth
- present
- strip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 160
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims description 29
- 150000002978 peroxides Chemical class 0.000 title description 9
- 239000003921 oil Substances 0.000 claims abstract description 26
- 235000019198 oils Nutrition 0.000 claims abstract description 26
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 19
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 18
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 17
- 239000011780 sodium chloride Substances 0.000 claims abstract description 16
- 239000003240 coconut oil Substances 0.000 claims abstract description 14
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 14
- 239000010670 sage oil Substances 0.000 claims abstract description 13
- 239000003349 gelling agent Substances 0.000 claims abstract description 9
- 239000002324 mouth wash Substances 0.000 claims description 62
- 229940051866 mouthwash Drugs 0.000 claims description 38
- 210000003298 dental enamel Anatomy 0.000 claims description 21
- 238000010186 staining Methods 0.000 claims description 18
- 239000000341 volatile oil Substances 0.000 claims description 17
- 239000000551 dentifrice Substances 0.000 claims description 15
- 229920002125 Sokalan® Polymers 0.000 claims description 11
- 235000016213 coffee Nutrition 0.000 claims description 11
- 235000013353 coffee beverage Nutrition 0.000 claims description 11
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 10
- 239000001683 mentha spicata herb oil Substances 0.000 claims description 10
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 10
- 235000019477 peppermint oil Nutrition 0.000 claims description 10
- 235000019721 spearmint oil Nutrition 0.000 claims description 10
- 239000009637 wintergreen oil Substances 0.000 claims description 10
- 235000020095 red wine Nutrition 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 244000269722 Thea sinensis Species 0.000 claims description 7
- -1 carboxypropyl Chemical group 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 229920002678 cellulose Polymers 0.000 claims description 5
- 235000010980 cellulose Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims description 4
- 229960001631 carbomer Drugs 0.000 claims description 4
- 235000010418 carrageenan Nutrition 0.000 claims description 4
- 239000000679 carrageenan Substances 0.000 claims description 4
- 229920001525 carrageenan Polymers 0.000 claims description 4
- 229940113118 carrageenan Drugs 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 244000061176 Nicotiana tabacum Species 0.000 claims description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 235000019504 cigarettes Nutrition 0.000 claims description 3
- 238000002845 discoloration Methods 0.000 claims description 3
- 230000000391 smoking effect Effects 0.000 claims description 3
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 229920000569 Gum karaya Polymers 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims description 2
- 235000021028 berry Nutrition 0.000 claims description 2
- 235000021438 curry Nutrition 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 235000010494 karaya gum Nutrition 0.000 claims description 2
- 229920001206 natural gum Polymers 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229960000502 poloxamer Drugs 0.000 claims description 2
- 235000013555 soy sauce Nutrition 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 abstract 1
- 239000000606 toothpaste Substances 0.000 description 34
- 238000012360 testing method Methods 0.000 description 33
- 239000000499 gel Substances 0.000 description 29
- 238000011282 treatment Methods 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 230000006872 improvement Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- 210000000214 mouth Anatomy 0.000 description 12
- 238000007654 immersion Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 230000001680 brushing effect Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 229940034610 toothpaste Drugs 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000003086 colorant Substances 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229940078916 carbamide peroxide Drugs 0.000 description 6
- 238000004737 colorimetric analysis Methods 0.000 description 6
- 210000004268 dentin Anatomy 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 210000003296 saliva Anatomy 0.000 description 6
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 6
- 235000006468 Thea sinensis Nutrition 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 235000020279 black tea Nutrition 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 201000002170 dentin sensitivity Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 208000007565 gingivitis Diseases 0.000 description 5
- 238000001543 one-way ANOVA Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 229910052573 porcelain Inorganic materials 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000007844 bleaching agent Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012894 fetal calf serum Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000007788 roughening Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000036347 tooth sensitivity Effects 0.000 description 4
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 3
- CSAVDNHVPJNKTC-UHFFFAOYSA-N 5-methyl-2-propan-2-ylcyclohexan-1-ol;5-methyl-2-propan-2-ylphenol;2,2,4-trimethyl-3-oxabicyclo[2.2.2]octane Chemical compound CC(C)C1CCC(C)CC1O.CC(C)C1=CC=C(C)C=C1O.C1CC2CCC1(C)OC2(C)C CSAVDNHVPJNKTC-UHFFFAOYSA-N 0.000 description 3
- 244000060011 Cocos nucifera Species 0.000 description 3
- 235000013162 Cocos nucifera Nutrition 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 244000061408 Eugenia caryophyllata Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 241000605986 Fusobacterium nucleatum Species 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 241000605862 Porphyromonas gingivalis Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 235000006886 Zingiber officinale Nutrition 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 239000010619 basil oil Substances 0.000 description 3
- 229940018006 basil oil Drugs 0.000 description 3
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 3
- 235000008397 ginger Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 229940076522 listerine Drugs 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 238000001314 profilometry Methods 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 235000002020 sage Nutrition 0.000 description 3
- 238000004626 scanning electron microscopy Methods 0.000 description 3
- 229960004029 silicic acid Drugs 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 238000007492 two-way ANOVA Methods 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- FBUKMFOXMZRGRB-XKJZPFPASA-N (+/-)9(10)-epome Chemical compound CCCCC\C=C/C[C@H]1O[C@H]1CCCCCCCC(O)=O FBUKMFOXMZRGRB-XKJZPFPASA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 235000009088 Citrus pyriformis Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 108091020100 Gingipain Cysteine Endopeptidases Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000366182 Melaleuca alternifolia Species 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000010676 Ocimum basilicum Nutrition 0.000 description 2
- 240000007926 Ocimum gratissimum Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 235000002912 Salvia officinalis Nutrition 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940096529 carboxypolymethylene Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000008369 fruit flavor Substances 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- 210000004195 gingiva Anatomy 0.000 description 2
- 201000005562 gingival recession Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000003641 microbiacidal effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000017095 negative regulation of cell growth Effects 0.000 description 2
- 231100001083 no cytotoxicity Toxicity 0.000 description 2
- 231100000065 noncytotoxic Toxicity 0.000 description 2
- 230000002020 noncytotoxic effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 235000019505 tobacco product Nutrition 0.000 description 2
- 230000036367 tooth discoloration Effects 0.000 description 2
- 230000036346 tooth eruption Effects 0.000 description 2
- 239000001841 zingiber officinale Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 229910001020 Au alloy Inorganic materials 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000018035 Dental disease Diseases 0.000 description 1
- 238000010159 Duncan test Methods 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241001291923 Fusobacterium nucleatum subsp. nucleatum Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 241001147462 Gigartinaceae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 108010029987 Salivary Proteins and Peptides Proteins 0.000 description 1
- 102000001848 Salivary Proteins and Peptides Human genes 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241001428151 Solieriaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000014151 Stomatognathic disease Diseases 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 206010043183 Teething Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 208000004509 Tooth Discoloration Diseases 0.000 description 1
- 206010044032 Tooth discolouration Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000010162 Tukey test Methods 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- XOYXESIZZFUVRD-UVSAJTFZSA-M acemannan Chemical compound CC(=O)O[C@@H]1[C@H](O)[C@@H](OC)O[C@H](CO)[C@H]1O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](O[C@@H]2[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O[C@@H]4[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]5[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]6[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]7[C@H]([C@@H](OC(C)=O)[C@H](OC)[C@@H](CO)O7)O)[C@@H](CO)O6)O)[C@H](O5)C([O-])=O)O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](CO)O2)O)[C@@H](CO)O1 XOYXESIZZFUVRD-UVSAJTFZSA-M 0.000 description 1
- 229960005327 acemannan Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 108010048202 alternansucrase Proteins 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 206010006514 bruxism Diseases 0.000 description 1
- IKZZIQXKLWDPCD-UHFFFAOYSA-N but-1-en-2-ol Chemical compound CCC(O)=C IKZZIQXKLWDPCD-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000805 composite resin Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000002455 dental arch Anatomy 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000004513 dentition Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 108010042194 dextransucrase Proteins 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 201000005581 enamel erosion Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000000445 field-emission scanning electron microscopy Methods 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003353 gold alloy Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000001847 jaw Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001220 mentha spicata Substances 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000036344 tooth staining Effects 0.000 description 1
- 229960001479 tosylchloramide sodium Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
Abstract
Abstract Oral care compositions consisting essentially of (i) a sea salt, preferably Dead Sea salt, and (ii) at least two oils selected from the group consisting of lemon peel oil, coconut oil and sage oil, and uses of such compositions to visibly whiten teeth by at least three shades. A delivery system for whitening teeth comprised of a strip formed by combining (i) Dead Sea salt and at least two of coconut oil, lemon peel oil, and/or sage oil and (ii) one or more gelling/thickening agents, wherein the strip is conformable to teeth surfaces and to interstitial spaces between teeth, without permanent deformation thereof, and is removably attached to a release liner. 10 L~4-z20 r1 r 2- 17--l F- -- 5 Page 1of 7
Description
Methods and Compositions for Visibly Whitening Teeth Without Peroxide
Field
Oral care products (mouthwashes, toothpastes, whitening strips, whitening gels applied via a pen) that create visibly whiter teeth and healthier-looking (pink) gums, without causing sensitivity associated with peroxide bleaching agents. Oral care products that reduce plaque and tartar, inflammation/gingivitis. Methods for neutralizing toxins secreted by bacteria in the human oral cavity - Gingipains, Leukotoxin A, and Lipopolysaccharides - that use natural and naturally-derived, non-cytotoxic, non-bactericidal ingredients.
Background
The therapeutic and medicinal benefits of Dead Sea salts have been reported in the scientific literature, typically in connection with diseases of the skin and joints, but also in conjunction with dental disease. See, European Patent Application EP1074245A2 (disclosing mineral salts, in particular Dead Sea salts, as an active ingredient in a mouthwash to assist in combatting bacteria and gum irritation and inflammation); see also, e.g., Uriel Katz et al., Scientific Evidence of the Therapeutic Effects of Dead Sea Treatments: A Systematic Review, Seminars in Arthritis and Rheumatism, Vol. 42, No. 2 (October 2012), pp.186-200, citing Z. Even-Paz, J. Shani, The dead sea and psoriasis: Historical and geographic background, Int J Dermatol, Vo. 28, No. 1 (1989), pp. 1-9 (345 g of mineral per liter (34.5% or 34.5 g/100 mL);
Essential oils have been used for the treatment of a variety of ailments since ancient times. The safety and efficacy of essential oils in dentistry have been reported in numerous clinical studies. See, e.g., Namrata Dagli et al., Essential oils, their therapeutic properties, and implication in dentistry: A Review J. Int. Soc. Prev. Community Dent. Vol. 5, No. 5 (2015), pp. 335-340.
Enamel is a quasi-translucent structure which allows the underlying dentin color to show through. Color of teeth (as perceived by others) is determined by the transparency of the enamel, the color tone of the underlying dentin and any imbedded staining contained between the dentin and the enamel surface. It is also associated with the light scattering and absorption
2019100469 02 May 2019 properties of the enamel and dentin.
Tooth discoloration (staining) is a multifactorial condition influenced by oral hygiene, diet (foods and beverages that are acidic and/or contain tannins and other chromogenic materials), tobacco usage, and aging. Extrinsic stains appear on the pellicle, the layer of adsorbed salivary proteins and other macromolecules on the dental enamel surface. These stains can be reduced, and future staining can be prevented, through brushing, rinsing and flossing. Deeper intrinsic staining is caused by long-term accumulation of chromogens within the enamel. Intrinsic staining is typically addressed through professional bleaching procedures (either inoffice or at-home) applying peroxide bleaching agents in bleaching trays and strips.
The present invention meets the long-felt but as yet unmet need for oral care products
- dentifrices, mouthwashes, whitening strips and whitening gels - that contain microbiome safe natural ingredients at clinicaIly-effective concentrations, to visibly whiten tooth enamel (and dental restorations) that have been stained by foods, beverages or smoking - at least three shades as measured using the VITA TOOTHGUIDE 3D MASTER® tooth shade grading system.
Improper brushing habits, consuming acidic foods and beverages, using at-home peroxidecontaining whitening products, and clenching or grinding teeth all cause teeth sensitivity.
These activities wear away and break down the enamel that protects teeth from harsh temperatures and decay. There has been and remains a need for oral care products that visibly whiten teeth without causing, and preferably, reducing teeth sensitivity. These needs are met by methods of the present invention.
Prior art mouthwashes containing chlorhexidine are effective in plaque removal, but have drawbacks including reported altered taste and discoloration/staining of teeth. Additionally, chlorhexidine has been shown ex vivo to have a cytotoxic effect on cells.
Beyond plaque control, prior art mouthwashes have been used to reduce gingivitis. Listerine® for example is described as an essential oil-containing, antimicrobial mouthrinse that helps to control supragingival plaque and gingivitis. The primary mechanism underlying the clinical activity of Listerine® is attributed to its microbiocidal activity. See, e.g., P. Pan et al.,
2019100469 02 May 2019
Determination of the in situ and bactericidal activity of an essential oil mouthrinse using a vital stain method J. Clin. Periodontol. Vol. 27, pp. 256-261 (2000); see also, L DePaola et al., Effect of an antiseptic mouthrise on salivary microbiota, American Journal of Dentistry Vol. 9, pp. 9395. (1996).
Listerine® and other alcohol-based mouthwashes are microbiocidal. They create dysbiosis - a condition where the balance good and bad bacteria is disrupted - and allow bacteria with harmful effects to dominate and cause conditions such as caries, gingivitis, periodontitis, and dry xerostomia, and halitosis.
There is a continued need for oral care products that create visibly whiter teeth and healthierlooking (pink) gums, improve plaque control, reduce gingivitis, but that do not cause dysbiosis in the oral microbiome. There are growing concerns that the widespread use of antibiotics/antimicrobial ingredients is creating resistant superbugs. See, for example, https://www.cbsnews.com/news/could-antibiotic-resistant-superbugs-become-a-bigger-killerthan-cancer-60-minutes-2019-04-21 (reporting on a study commissioned by the British government which estimates that by 2050,10 million people worldwide could die each year from antibiotic resistant bacteria; more than currently die from cancer.) These needs are met by the methods and compositions of the present invention.
There also exists a need to maintain a healthy oral microbiome by administering a noncytotoxic oral care product, preferably in the form of a solution (also known in the dental arts as a mouthwash), and thereby reducing levels of glucansucrases, Leukotoxin A, Gingipains, and lipopolysaccharides from P. gingivalis without causing a decrease in the levels of common bacteria in the oral cavity-Streptococcus mutans, Porphyromonas gingivalis, Staphylococcus aureus, Fusobacterium nucleatum, subsp. nucleatum Knorr and Fusobacterium nucleatum Strain W1481. These needs are also met by the methods and compositions of the present invention.
Brief Description of the Figures
2019100469 02 May 2019
Figure 1 illustrates an embodiment of the whitening strip of the present invention [10] attached to a release liner [20], This embodiment is configured to be applied to the bottom row of teeth.
Figure 2 illustrates an embodiment of the whitening strip of the present invention [11] attached to a release liner [20], This embodiment is configured to be applied to the top row of teeth.
Figure 3 illustrates the VITA TOOTHGUIDE 3-D MASTER® system.
Figure 4 lists, in table form, shade classifications in the VITA TOOTHGUIDE 3-D MASTER® system and a corresponding Shade Number ranging from 1 to 26.
Figure 5 illustrates a 7-point plot used by an observer for scoring the chroma and hue of a tooth.
Figures 6-10 are tables that present, respectively, improvement (i.e., lightening) in tooth shade by at least 3, 4, 5, 6 and 7 shades, and are based on the TOOTHGUIDE 3-D MASTER® system and corresponding Shade Number (as presented in Figure 4).
Summary
The present invention is directed to methods of whitening tooth enamel (and dental restorations) by administering to the enamel (or dental restoration) an oral care product - mouthwash, toothpaste, whitening strip, or whitening gel applied via a pen - comprised of (a) a Dead Sea salt, at a concentration of from 0.5% to 3.0%; and (b) a whitening complex consisting of two or three essential oils selected from the group consisting of (i) lemon peel oil, (ii) coconut oil, and (iii) sage oil.
A first key attribute of the oral care products present invention is the ability to whiten without using a peroxide bleaching agent. Non-limiting examples of peroxide bleaching agents include hydrogen peroxide, calcium peroxide, carbamide peroxide, and mixtures thereof.
Two additional key attributes of the compositions and methods of the present invention are non-cytotoxicity within the framework of ISO 10993-5 Biological Evaluation of Medical
2019100469 02 May 2019
Devices - Tests For In Vitro Cytotoxicity, and not being bactericidal, each described in greater detail below
Oral care products of the present invention do not contain: artificial colors, dyes or flavors; paraben or formaldehyde preservatives; sodium lauryl sulfate or sodium laureth sulfate; petroleum-derived glycerin; or genetically modified organisms (GMOs).
A key aspect of mouthwash embodiments of the oral care compositions of the present invention is the absence of ethyl alcohol. These mouthwashes are sometimes described as alcohol free - a term that is to be understood by the person having ordinary skill in the art as referring to ethyl alcohol. Accordingly, alcohol free mouthwashes may contain other alcohols, including menthol or glycerol.
A further key aspect of mouthwash embodiments of the oral care compositions of the present invention is the absence of fluoride.
Detailed Description
By the term dentifrice is meant a preparation for cleansing and polishing the teeth, that may, and preferably does provide one or more therapeutic benefits (as described below). As will be understood by the skilled artisan, a dentifrice (also referred to in the art and in this application as a toothpaste) may be formulated as a paste, gel or powder and is preferably applied with a toothbrush.
Dentifrice embodiments of the present invention are administered by dispensing at least about 0.25 grams of a dentifrice of the present invention (commonly described in the scientific literature and in recommendations from dental professionals and toothpaste manufacturers as a pea sized amount), and more preferably at least 0.50 grams of dentifrice, and brushing the teeth for at least 30 seconds, preferably for at least 60 seconds, and still more preferably for at least 120 seconds, at least once per day, in the evening prior to going to sleep. In certain preferred embodiments, the dose of toothpaste per administration ranges from about 0.4 to about 0.6 grams.
2019100469 02 May 2019
By brushing is meant placing the bristles of a toothbrush in contact with the teeth, preferably at an angle of about 45 degrees to the gum line (where the gums and teeth meet), and moving the bristles in gentle, short strokes along the outer surfaces (cheek side), the inside surfaces (tongue side) and the chewing surfaces of all teeth. The strokes may be in a back-and-forth motion (side-to-side, or up-and-down) or a circular motion. After brushing, the dentifrice is expectorated.
Still more preferably, dentifrice embodiments of the present invention are administered by brushing the teeth for at least 30 seconds, preferably for at least 60 seconds, and still most preferably for at least 120 seconds, twice daily - once in the evening prior to going to sleep; and once in the morning after breakfast.
By the term mouthwash is meant a solution that is swished, preferably vigorously, around the mouth, and then expectorated, thereby cleaning the mouth and making the breath smell pleasant.
Mouthwash embodiments of the present invention are administered by swishing about 15-20 ml (about 0.5-0.75 fluid ounces) in the mouth, for a period of time sufficient to contact the teeth, the gums, the roof of the mouth and the tongue. Preferably, mouthwash is swished for at least 30 seconds, preferably for at least 60 seconds, at least once per day, in the evening prior to going to sleep.
Still more preferably, mouthwash embodiments of the present invention are administered for at least 30 seconds, preferably for at least 60 seconds, most preferably for at least 120 seconds, at least once per day twice daily -once in the evening, after brushing prior to going to sleep; and once in the morning after brushing after breakfast.
In especially preferred embodiments, a person practicing a method ofthe present invention (e.g., a consumer or a patient) brushes his/her teeth with a dentifrice of the invention for at least 30 seconds, more preferably for at least 60 seconds, and then swishes a mouthwash of the invention in his/her mouth for a period of at least 30 seconds, preferably at least 60 seconds - a
2019100469 02 May 2019 period of time sufficient for the mouthwash to contact the teeth, the gums, the roof of the mouth and the tongue.
Persons practicing a method of the present invention are instructed to abstain from drinking or eating for at least 30 minutes after administering the oral care compositions of the invention; and, since oral care compositions of the invention are not intended for ingestion, to expectorate the oral care composition after use (i.e., brushing in the case of a dentifrice, or swishing in the case of a mouthwash).
As used in the present application the term dental restoration is to be understood to mean bridges, crowns, veneers, inlays, and onlays made of porcelain or composite resin.
By the term whitening strip is meant a hydratable adhesive film that adheres (sticks) to teeth.
By the term whitening pen is meant a gel that is stored in, and administered from, a pen applicator onto the surface of the teeth.
As used in the present application, an essential oil is a mixture of terpenic hydrocarbons, especially monoterpenes and sesquiterpenes, and oxygenated derivatives such as aldehydes, ketones, epoxides, alcohols, and esters.
Non-cytotoxicity of oral care products of the present invention is confirmed within the framework of ISO 10993-5:2009 based on the widely-used Trypan blue exclusion test. (Trypan blue is a colorant which stains dead cells, i.e., cells with loss of membrane integrity.) More particularly, Balb/c 3T3 clone A31 cells (ATCC CCL 163; 86th passage) are seeded in multi-well plates (24 wells, each 15.5 mm in diameter) at the starting density of 30,000 cells/cm2 in culture medium - Dulbecco's Modified Eagle Medium (DMEM) - supplemented with 10 % (v/v) fetal calf serum (FCS). No antibiotics are used. Cultures are incubated at 37°C in a humidified atmosphere containing 5% (v/v) CO2, for 24 hours, and are examined with a microscope to verify a sub-confluent monolayer with less than de minimus alteration in morphology. Culture medium is withdrawn and replaced with a solution of one of the following: oral care products of the present invention at 5,000 qg/mL, as well as dilutions 1,500 qg/mL, 500 qg/mL and 150 qg/mL; a negative control (phenol, Chemical Abstract Service No. 108-95-2, 0.64mg/mL); and
2019100469 02 May 2019 a positive control (DMEM supplemented with 10 % (v/v) FCS and 1% antibiotics (v/v). A positive control is defined as statistically significant (30% or greater) inhibition of cell growth as compared to the negative control.
Wells are incubated at 37°C in a humidified atmosphere containing 5 % (v/v) CO2, for a 24-hour period. Photomicrographs are taken (320x magnification) showing the cell layer in contact with the negative control, the positive control and the oral care product of the present invention. Morphology and cell density of the cultures are observed. At the end of the incubation period, culture medium is removed. Cells are detached for two minutes using 250 pL trypsin (0.05 % (w/v) in Hank's balanced solution Ca++ and Mg++ free supplemented with 1 mM EDTA. 250 pL of a Trypan blue solution at 0.2 % (w/v) in 0.15 M NaCI and 10 % (v/v) FCS are added. Cells are incubated for two minutes. Living cells (uncolored) are counted using a hemocytometer. Cell morphology and cell density of medium treated with 5,000 pg/mL of the oral care product of the present invention are observed to be comparable to those of negative control; neither shows statistically significant (30% or greater) inhibition of cell growth. In contrast, cells treated with the positive control show greater than 50% inhibition on cell growth.
Oral care products of the present invention are non-bactericidal by which is meant that when administered at a concentration of 5 mg/ml in a 10 ml solution also containing 0.1 ml of artificial saliva (AFNOR NF S91-141, Pickering Laboratories, Inc. Mountain View, California) with 1 x 105 to 1 x 106 colony forming units (CFUs) of a bacteria selected from the group of S. mutans, P. gingivalis, S. aureus, Fusobacterium nucleatum subsp. nucleatum Knorr (ATCC® 25586D-5™), and Fusobacterium nucleatum Strain W1481, the bacterial count (i.e., number of CFUs) does not decrease.
A consumable chromogenic substance is a food, beverage or tobacco product that causes tooth staining or discoloration. Non-limiting examples of consumable chromogenic foods include berries, soy sauce and curries. Non-limiting examples of consumable chromogenic beverages include coffee, tea and red wine. Consumable chromogenic tobacco products include cigarettes and smokeless tobacco (that is chewed).
2019100469 02 May 2019
The phrase at least one means one or more, and also includes individual components as well as mixtures/combinations.
A dental arch is the crescent arrangement of teeth, one on each jaw, that together constitute the dentition.
Numbers used in describing quantities of ingredients and/or reaction conditions are to be understood as being modified in all instances by the term about.
Unless otherwise indicated, percentages, parts and ratios are to be understood as based upon the total weight of the composition.
Numerical ranges are meant to include numbers within the recited range, and combinations of subranges between, the given ranges. For example, a range from 1-5, includes 1, 2, 3, 4 and 5, as well as subranges such as 2-5, 3-5, 2-3, 2-4, 1-4, etc.
Dead Sea salt is a mixture of natural hygroscopic minerals and micronutrients found in the Dead Sea and is comprised of sodium chloride, potassium chloride, calcium chloride and magenesium bromide. S. Halevy et al., J. Eur. Acad. Dermatol. Venereol., Vol. 9, pp. 237-242 (1997). Dead Sea salt also contains separate ions: Br-, Rb+, Li+, Fe3+, AI3+, SO42-, Sr2+ and Mn2+. See, e.g.,
I.L. Schamberg, Treatment of psoriasis at the Dead Sea, Int J Dermatol, Vol. 17, No. 6 (1978), pp. 524-525; Paz and Shani, supra.
Dead Sea salt is present in oral care products of the invention at a concentration of less than about 3%, preferably a concentration of from about 0.1% to 2%, still more preferably a concentration of from about 0.5% to about 1.5%.
Citrus limon (lemon) peel oil is the volatile oil obtained from the peel of Citrus limon.
Salvia officinalis (sage) oil is the essential oil derived from the herbal plant, Salvia officinalis.
Cocos nucifera (coconut) oil is an oil obtained from the kernel or seed of Cocos nucifera.
In certain preferred embodiments, whitening oral care products of the present invention contain coconut oil and lemon peel oil in a ratio of about 1:1.
2019100469 02 May 2019
In other preferred embodiments, whitening oral care products of the present invention contain coconut oil, lemon peel oil, and sage oil in a ratio of about 1:1:1.
Xylitol is the pentahydric alcohol.
Aloe vera leaf juice useful in the present invention preferably contains (i) glycosides at a concentration of at least about 1%, preferably at least about 2%, and still more preferably at about 3%, as well as (ii) at least two, preferably three, anti-inflammatory agents selected from the group of anthraquinones, sterols, auxins and gibberellins and (iii) and immunomodulatory muccopolysachharides, preferably Acemannan.
Spearmint oil is the volatile oil obtained from the leaves of Mentha viridis (also known as Mentha spicata).
Peppermint oil is a volatile oil obtained from the whole plant Mentha piperita.
Wintergreen oil is the volatile oil obtained from the leaves of Gaultheria procumbens.
In certain embodiments, oral care products of the present invention contain one or more essential oils selected from the group consisting of spearmint oil, Wintergreen oil, and peppermint oil.
In one even more preferred embodiment, oral care products of the present invention include peppermint oil and one of Wintergreen oil or spearmint oil.
In another even more preferred embodiment, oral care products of the present invention include Wintergreen oil and one of peppermint oil or spearmint oil.
In a still further even more preferred embodiment, oral care products of the present invention include spearmint oil and one of peppermint oil or Wintergreen oil.
In especially preferred embodiments, the oral care products of the present invention contain spearmint oil, peppermint oil, and Wintergreen oil.
Menthol, an alcohol that can be isolated from peppermint or other mint oils, can also be used
2019100469 02 May 2019 in oral care products of the present invention.
In certain embodiments, oral care products of the present invention also preferably include oils of one or both of Ocimum basilicum (basil) or Eugenia caryophyllus (clove flower).
In certain preferred embodiments of the invention, basil oil is present at a concentration of up to about 0.5%.
Other essential oils that may be included in oral care products of the present invention include Melaleuca alternifolia (tea tree) leaf oil, the oil distilled from the leaves of the Melaleuca alternifolia, and Zingiber officinale (ginger) root oil, which is obtained from the dried rhizomes of Zingiber officinale.
Dentifrice embodiments of the present invention may include mild abrasives (to remove debris and residual surface stains), humectants (to prevent water loss in the toothpaste), thickening products, also known in the art as binders (to stabilize the toothpaste formula), flavoring products (for taste) and detergents (to create foaming action).
Mild abrasives suitable for use in the toothpaste embodiments of the present invention include calcium carbonate, dehydrated silica gels, hydrated aluminum oxides, magnesium carbonate, phosphate salts and silicates. Silica, also called silicone dioxide, bentonite clay and hydrated silica are minerals. Some toothpastes of the present invention preferably contain hydrated silica.
Humectants that may be, and preferably are, ingredients in toothpastes of the present invention include glycerin, preferably vegetable glycerine, propylene glycol, and sorbitol.
Glycerin, a sugar alcohol that can be synthesized or obtained from natural sources, is an especially preferred humectant used in toothpastes of the invention. Preferably, vegetable glycerin is used in oral care compositions of the present invention.
Non-limiting examples of thickening products that may be, and preferably are included in toothpaste embodiments of the present invention include gums and colloids. Preferred colloids are of marine origin, even more preferably seaweeds.
2019100469 02 May 2019
Two preferred gums are xanthan gum and biosaccharide gum-1; both are polysaccharides derived from the fermentation of carbohydrates. Xanthan gum is derived from glucose or corn syrup. Biosaccharide gum-1 is derived from sorbitol.
Carrageenan, a polysaccharide hydrocolloid obtained from edible red seaweeds in the Gigartinaceae or Solieriaceae families, may be, and preferably is, present in toothpastes of the invention.
Examples
The following examples illustrate compositions and methods of practicing of the present invention in some of its embodiments; the examples should not be construed as limiting the scope of the invention. Other embodiments will be apparent to one skilled in the art from consideration of the specification and examples. It is intended that the specification, including the examples, is considered exemplary only without limiting the scope and spirit of the invention. Some of the examples illustrate preferred embodiments of the invention. Variations of these preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, unless otherwise indicated herein or otherwise clearly contradicted by context, the inventions include all modifications and equivalents of the subject matter disclosed and recited in the claims appended hereto as permitted by applicable law.
Whitening Dentifrice of the Invention
Whitening toothpastes of the present invention contain the following ingredients at the following concentrations.
Dead sea salt is present in whitening toothpastes of the present invention at a concentration of from about .5% to about 3.0%, preferably from about .75% to about 1.75%, and most preferably from about 1.0% to about 1.5%.
2019100469 02 May 2019
In whitening toothpastes of present invention in which coconut oil is a component of the whitening complex, coconut oil is present at a concentration of from about 0.001% to about 5%, preferably from about .005% to about 1%, and most preferably from about .09% to about .9%.
In whitening toothpastes of the present invention in which lemon peel oil is a component of the whitening complex, lemon peel oil is present at a concentration of from about .001% to about 5%, preferably from about .005% to about 1%, and most preferably from about .09% to about .9%.
In whitening toothpastes of the present invention in which sage oil is a component of the whitening complex, sage oil is present at a concentration of from about .001% to about 5%, preferably from about .005% to about 1%, and most preferably from about .09% to about .9%.
Aloe vera leaf juice is preferably a component of the whitening toothpastes of the present invention at a concentration of from about 10% to about 90%, preferably from about 20% to about 85%, and most preferably from about 40% to about 70%.
Xylitol is preferably a component of the whitening toothpastes of the present invention at a dose of about 0.1 gram/brushing. The concentration of xylitol can range from about 5% to about 30%, preferably from about 15% to about 25%, and most preferably from about 17% to about 22%.
Peppermint oil, when present in whitening toothpastes of the present invention, is included at a concentration of from about .001% to about .07%, preferably from about .005% to about .06%, and most preferably from about .01% to about .03%.
Spearmint oil, when present in whitening toothpastes of the present invention, is included at a concentration of from about .01% to about 2%, preferably from about .05% to about 1.5%, and most preferably from about .09% to about 1.2%.
Wintergreen oil, when present in whitening toothpastes of the present invention, is included at a concentration of from about .05% to about 1%, preferably from about .1% to about .5%, and
2019100469 02 May 2019 most preferably from about .2% to about .4%.
Basil oil, when present in whitening toothpastes of the present invention, is included at a concentration of from about .001% to about .05%, preferably from about .005% to about .03%, and most preferably from about .02% to about .035%.
Clove flower oil, when present in whitening toothpastes ofthe present invention, is included at a concentration of from about .001% to about .05%, preferably from about .005% to about .04, and most preferably from about .01% to about .03%.
Vegetable glycerin is preferably present in whitening toothpastes of the present invention at a concentration of from about 5% to about 20%, preferably from about 8% to about 12%, and most preferably about 10%.
Carrageenan is preferably present in whitening toothpastes of the present invention at a concentration of from about .05% to about 5%, preferably from about .1% to about .3%, and most preferably from about .15% to about .25%.
Xanthan gum is preferably present in whitening toothpastes of the present invention at a concentration of from about .1% to about 1.0%, preferably from about .4% to about .8%, and most preferably from about .5% to about .7%.
Titanium dioxide may be used in whitening toothpastes of the present invention at a concentration of from about .01% to about 1.0%, preferably from about .03% to about .07%, and most preferably from about .4% to about .6%.
Hydrated silica may be used in whitening toothpastes ofthe present invention at a concentration of from about 5% to about 25%, preferably from about 10% to about 20%, and most preferably from about 14% to about 17%.
Sodium methyl cocoyl taurate is preferably used in whitening toothpastes of the present invention at a concentration of from about .3% to about 2%, preferably from about .5% to about 1.5%, and most preferably from about .8% to about 1.2%.
2019100469 02 May 2019
Whitening Mouthwash of the Invention
Whitening mouthwashes of the present invention contain the following ingredients at the following concentrations.
Dead Sea salt is present in whitening mouthwashes of the present invention at a concentration of from about 0.5% to about 5%, preferably from about .75% to about 3%, and most preferably from about 1% to about 2%.
In whitening mouthwashes of the present invention in which coconut oil is a component of the whitening complex, coconut oil is present at a concentration of from about 0.001% to about 5%, preferably from about 0.1% to about 0.7%, and most preferably from about 0.15% to about 0.6%.
In whitening mouthwashes of the present invention in which lemon peel oil is a component of the whitening complex, lemon peel oil is present at a concentration of from about .001% to about 5%, preferably from about 0.1% to about .7%, and most preferably from about .15% to about .6%.
In whitening mouthwashes of the present invention in which sage oil is a component of the whitening complex, sage oil is present at a concentration of from about .001% to about .09%, preferably from about .005% to about .05%, and most preferably from about .01% to about .03%.
Aloe vera leaf juice is preferably present in whitening mouthwashes of the present invention at a concentration of from about 10% to about 90%, preferably from about 20% to about 85%, and most preferably from about 50% to about 70%.
Xylitol is preferably present in whitening mouthwashes of the present invention at a concentration of from about 5% to about 30%, preferably from about 7% to about 15%, and most preferably from about 8% to about 12%.
Basil oil, when present in whitening mouthwashes of the present invention, is included at a concentration of from about .005% to about .5%, preferably from about .01% to about .2%, and
2019100469 02 May 2019 most preferably from about .02% to about .1%.
Clove flower oil, when present in whitening mouthwashes of the present invention, is present at a concentration of from about .005% to about .075%, preferably from about .01% to about .04%, and most preferably from about .01% to about .03%.
Peppermint oil, when present in whitening mouthwashes of the present invention, is included at a concentration of from about .005% to about .12%, preferably from about .01% to about .1%, and most preferably from about .02% to about .09%.
Spearmint oil, when present in whitening mouthwashes of the present invention, is included at a concentration of from about .01% to about 1%, preferably from about .02% to about .17%, and most preferably from about .05% to about .15%.
Wintergreen oil, when present in whitening mouthwashes of the present invention, is included at a concentration of from about .03% to about 1%, preferably from about .05% to about .5%, and most preferably from about .1% to about .45%.
Toothpastes and mouthwashes of the present invention may also, optionally, in place of Wintergreen oil, peppermint oil and/or spearmint oil, include flavorants and/or taste masking products known in the art materials. The flavorants may be of natural or synthetic origin. Nonlimiting examples of such flavorants include but are not limited to fruit flavors such as cherry, strawberry, lemon, lime, orange, watermelon, or a mixture of fruit flavors (sometimes known as tutti frutti).
Whitening mouthwashes of the invention can lighten teeth by up to 7 shades.
Whitening Strip
Whitening strips of the present invention (also referred to in the examples below as Test Strips) consist essentially of (i) Whitening Composition in which (a) sea salt, preferably Dead Sea salt, and (b) a Whitening Complex consisting of two, and preferably three, of coconut oil, lemon peel oil and/or sage oil are added to a Gel Carrier and (ii) a two-sided flexible strip that is (a) safe for contact with the structures of the oral cavity of humans (i.e., non-toxic, non
2019100469 02 May 2019 corrosive, and non-irritating), (b) conformable to a plurality of adjacent teeth surfaces and to interstitial spaces between teeth, without permanent deformation thereof.
The Gel Carrier provides adhesive attachment sufficient to hold a strip in place for a desired period of time to allow the Active Ingredient(s) to be delivered to, and act on, the teeth surface, and thereby provide a desired clinical outcome - namely, whitening of teeth by at least two shades, preferably at least three shades, more preferably at least four shades, even more preferably at least five shades, still more preferably at least six shades; and, in certain embodiments, by at least seven shades. See discussion below for methods of measuring whitening (i.e., lightening) of teeth.
The Gel Carrier is comprised of at least one gelling agent known in the art and (a) is generally recognized to be safe for oral use, (b) does not readily dissolve in saliva, and (c) does not react with, inactivate, or cause the degradation or loss of desired function of Active Ingredients in the Whitening Composition.
Non-limiting examples of suitable gelling agents that may, and preferably are, components of the Gel Carrier, include: carboxypolymethylene, carboxymethyl cellulose, carboxypropyl cellulose, poloxamer, carrageenan, magnesium aluminum silicate (commercially-available under the tradename Veegum® from Vanderbilt Materials, LLC), carboxyvinyl polymers (including Carbomer), and natural gums such as gum karaya, xanthan gum, guar gum, gum arabic, gum tragacanth, and mixtures thereof.
Carbomers are a class of homopolymers of acrylic acid crosslinked with an allyl ether of pentaerythritol, an allyl ether of sucrose, or an allyl ether of propylene. One preferred Carbomer gelling agent is carboxypolymethylene, available from B. F. Goodrich Company under the tradename Carbopol®. Particularly preferred Carbopols include Carbopol® 934, 940, 941, 956 and mixtures thereof. Especially preferred is Carbopol® 956.
Another preferred gelling agent is polyvinylpyrrolidone. In certain embodiments polyvinylpyrrolidone is of a molecular weight in a range of 1,000,000 to 1,500,000. In certain embodiments, polyvinylpyrrolidone has molecular weight of about 50,000 to about 300,000.
2019100469 02 May 2019
Additional gelling agents that are suitable for use in the whitening strips of the present invention include celluloses (hydroxy ethyl or propyl cellulose, ethyl cellulose) and Polyox® water-soluble resins available from Dow Corning (Midland, Michigan).
Polyox® resins are nonionic, high molecular weight water-soluble poly (ethylene oxide) polymers with molecular weights ranging from 100,000 to about 8,000,000.
Gantrez® copolymers - monoalkyl esters of poly (methyl vinyl ether/maleic acid) with varying ester groups - available from Ashland are also suitable for to thicken the whitening compositions and promote adhesion between the strip and teeth surfaces.
Gelling agents as described above is/are preferably present in the Whitening Composition at a concentration from about 0.1% to about 15%, preferably from about 1% to about 10%, more preferably from about 2% to about 8%, and most preferably from about 4% to about 7%, by weight.
The viscosity and tackiness of the Whitening Composition(s) are such that the whitening strip (a) remains adhesively attached to a plurality of adjacent teeth for the desired contact time without substantial slippage under friction from the lips, tongue, and other soft tissue rubbing against the strip (e.g., during mouth movements associated with talking) and (b) can be easily removed by the wearer by applying a peel force using a finger or fingernail, and not requiring the use of an instrument, a chemical solvent, or undue friction.
In preferred embodiments, the peel force required to remove the strip is from about 1 gram to about 50 grams for a strip that is 1.5 cm in width. Even more preferably, for a strip that is 1.5 cm in width, the peel force is from about 5 grams to about 40 grams, and more preferably from about 10 grams to about 30 grams.
Preferably, the Whitening Composition has a viscosity of from about 200 to about 1,000,000 at low shear rates. More preferably, the viscosity is from about 100,000 to about 800,000 cps, and even more preferably the viscosity is from about 400,000 to about 600,000 cps.
2019100469 02 May 2019
While the Whitening Composition(s) is preferably in the form of a gel, it can also be in the form of a liquid or paste that meets the above viscosity and tackiness profile.
The Whitening Composition is applied to a first side of the flexible strip; a release liner (defined below) is placed on top of the Whitening Composition. The first side is applied to the teeth surface after the release liner is removed.
The time required for the Active Ingredients to be delivered to and act upon the teeth surface, and thereby provide a desired clinical outcome (whitening) can range from several minutes to several hours. Accordingly, a second side of the strip (opposite the side covered by the release liner) is designed to serve as a protective barrier to minimize, and preferably substantially prevent, the Whitening Composition from coming into contact with saliva as well as the wearer's lips, tongue, and other soft tissue surrounding the teeth (e.g., papilla, marginal gingiva, gingival sulcus, inter dental gingiva, gingival gum structure on lingual and buccal surfaces up to and including muco-gingival junction and the pallet).
In preferred embodiments of the present invention the whitening strip is applied to the teeth for a period of time of at least about 5 minutes, preferably at least about 10 minutes, more preferably for at least about 15 minutes, even more preferably for at least about 20 minutes, most preferably for at least about 30 minutes; but not for longer than about 60 minutes.
The flexible strip component of the whitening strip may be a single layer of material or a laminate, or a plurality or layers of materials or laminates, a heterogeneous mixture of ingredients, separate stripes or spots or other patterns of ingredients, or a combination of laminates, layers, stripes, and/or spots of ingredients. The one or more materials/laminates and other components/ingredients (i) meet the flexural rigidity characteristics described below.
The flexible strip may be constructed of polymers, natural and synthetic woven materials, nonwoven materials, foil, paper, rubber, and combinations thereof.
In preferred embodiments, the material(s) used to construct the flexible strip is/are polymers that are substantially water impermeable and/or polymers or gelling agents (described above) that are hydratable. Suitable polymers include, but are not limited to, polyethylene,
2019100469 02 May 2019 ethylvinylacetate, ethylvinyl alcohol, polyethylene, polyesters (such as Mylar®, manufactured by DuPont), fluoroplastics (such as Teflon®, manufactured by DuPont), and combinations thereof.
In certain embodiments, the whitening strip of the invention is less than about 2 mm thick, preferably less than about 1 mm thick, and more preferably less than about 0.5 mm thick, and even more preferably less than about 0.1 mm thick.
Preferably, the whitening strip of the invention is configured in a shape that has rounded corners, by which is meant not having any sharp angles or points.
The size (length and width) of the whitening strip of the invention will vary based upon one or more factors, including the number of teeth to be treated (i.e., whitened), the size of the teeth, and personal preference of the wearer.
Preferably, the whitening strip of the invention is of a length that covers at least the front 6-10 teeth of the upper or lower rows of teeth that are visible when the wearer is smiling.
Optionally, the strip covers the entire upper and/or lower rows of teeth.
In certain embodiments, the length of the whitening strip of the invention is from about 2 cm to about 12 cm, preferably from about 4 cm to about 9 cm.
The width of the whitening strip of the invention will vary depending on whether the strip is intended to cover the front surface of the teeth, or wrap around the teeth and cover both surfaces of the teeth.
In certain embodiments, the width of the whitening strip of the invention is from about 0.5 cm to about 4 cm, preferably from about 1 to about 2 cm.
The flexural stiffness of the whitening strip of the invention is determined by strip thickness, strip width, and material modulus of elasticity. One method for measuring flexural stiffness of a polymeric strip is ASTM D2912-95, which employs a strain gauge wired to a microammeter.
In accordance with this method, the rigidity of the strip is read directly from the microammeter and expressed as grams per centimeter of strip width. A non-limiting, but preferred,
2019100469 02 May 2019 instrument for measuring flexural stiffness is Handle-O-Meter®, available from Thwing-Albert
Instrument Co. of Philadelphia, Pa.
In certain embodiments, the whitening strip of the invention has a flexural stiffness of less than about 5 grams/cm, preferably a flexural stiffness less than about 4 grams/cm, more preferably less than about 3 grams/cm, and most preferably from about 0.1 grams/cm to about 1 grams/cm.
In other embodiments, the flexural stiffness of the whitening strip of the invention is substantially constant and does not significantly change during normal use. For example, in these embodiments, the strip does not need to be hydrated for the strip to achieve flexural stiffness in the above-specified ranges.
Low flexural stiffness (in the above-specified ranges) is an important property of the whitening strip of the invention, which allows the strip to drape over, and conform to, the contoured surfaces of teeth of the wearer's mouth, including gaps between adjacent teeth. By designing strips to have a flexural stiffness within the above-specified ranges, there are minimal residual forces within the strip that would cause it to return to an original (i.e. starting) configuration which is substantially flat.
Additionally, the flexibility (low flexural stiffness) of the whitening strip of the invention enables the strip to contact soft tissue over an extended period of time without physical irritation.
The whitening strip of the invention may, in certain embodiments, be configured to have shallow recesses to create reservoirs (depots) for the Whitening Composition of the Invention and/or different oral care products.
The release liner may be formed from any material which exhibits less affinity for the Whitening Composition than the Whitening Composition exhibits for (a) itself and (b) for the flexible strip. The release liner preferably comprises a rigid sheet of material such as polyethylene, paper, polyester, or other material which is then coated with a non-stick type material. The release liner material may be coated with wax, silicone, polyester such as Teflon®, fluoropolymers, or other non-stick type materials. The release liner material may crack when the strip is flexed.
2019100469 02 May 2019
The release liner may be cut to substantially the same size and shape as the strip or the release liner may be cut larger than the strip to provide a means for separating the release liner from the strip.
The release liner may have a tab, or be scored, to facilitate separation from the strip. Alternatively, the release liner may be two overlapping pieces in a bandage-type design.
In preferred embodiments, the Whitening Composition(s) is homogeneous, and is preferably coated onto the strip in a uniform manner.
In alternate embodiments, more than one Whitening Composition(s) may be coated onto the strip in a series of separate stripes or spots or other patterns of ingredients.
In one preferred embodiment, whitening strips of the present invention include Dead Sea salt, coconut oil, lemon peel oil and sage oil, each a concentration of up to about 10.0%, preferably each a concentration of up to about 5.0%, and even more preferably at a concentration of at least about 3.0%.
Each of these ingredients is preferably present at a concentration of up to about 800 grams, and more preferably up to about 400 grams.
In one especially preferred embodiment, whitening strips of the present invention include Dead Sea salt, coconut oil, lemon peel oil and sage oil in a ratio of about 1:1:1:1.
In one especially preferred embodiment, the whitening strips of the present invention preferably include a hydratable adhesive matrix comprised of glycerol, carbomer and a cellulose, preferably carboxymethylcellulose.
Whitening strips of the invention can lighten teeth by up to 12 shades.
Whitening Gel (Applied via Pen Applicator)
Certain embodiments of the present invention are directed to methods for visibly whitening teeth (and removing stains) and/or preventing or reducing the amount of staining by using a Whitening Pen in which a gel composition is stored in, and dispensed from, a pen application.
2019100469 02 May 2019
The gel composition is preferably the Whitening Composition that is used in the whitening strips of the present invention.
Assessment of Tooth Whitening
Improvement in tooth shade (i.e., lightening) achieved by practicing the methods of the present invention can be determined by visually assessing the tooth before, during and after treatment in accordance with the present invention by choosing the closest shade from a dental shade guide that matches the color of the tooth.
Shade can be, and in preferred embodiments of the present invention, is described according to the Munsell color space in terms of value, chroma, and hue, each defined below.
Value indicates the lightness of a color. Lightness is defined by the Commission Internationale de I'Eclairage (CIE) as the brightness of an area judged relative to the brightness of a similarly illuminated area that appears to be white or highly transmitting.
Chroma is the degree of color saturation, and is defined by the CIE as the colourfulness of an area judged as a proportion of the brightness of a similarly illuminated area that appears white or highly transmitting.
Hue is the attribute of a color that enables the clinician to distinguish between different families of color, and defined as the attribute of a visual perception according to which an area appears to be similar to one of the colours: red, yellow, green, and blue, or to a combination of adjacent pairs of these colours considered in a closed ring. Hue is represented by A, B, C or D on the commonly used VITA Classic shade guide.
In certain embodiments, improvement in tooth shade (i.e., lightening) is measured using the VITA TOOTHGUIDE 3-D MASTER® system - a dental shade guide comprised of 26 shade tabs based on a color classification principle where the values of lightness, chroma, and hue have been positioned an equal distance from each other. See FIG. 3.
The VITA TOOTHGUIDE 3-D MASTER® system is organized into five primary value levels, arranged from the lightest (value level 1) to the darkest (value level 5), left to right. These
2019100469 02 May 2019 values, in turn, are further distributed (subdivided) based on chroma and hue. Within each of the five groups, shade tabs are arranged vertically according to chroma (pale to saturated and horizontally according to hue (yellowish to reddish).
US Patent Application Pre-Grant Publication 2009/0233253 describes the VITA TOOTHGUIDE 3D MASTER® system as follows: Shades are assigned to linear groups numbered 1 through 5 denoting different value levels. Level 1 value is higher (closer to white). As the group number increases toward 5, value is lower (closer to black). In groups 2, 3, and 4, shade tabs are linearly arranged by hue. L group tabs, on the left side of each value grouping, are more prominent in the yellow range of color. R group tabs, arranged on the right side of each value grouping, are more prominent in the red range of color. M group tabs, arranged in the middle of each value grouping, are in-between in hue with a balance of yellow and red. All tabs in each value group are also arranged vertically, one behind the other. Tabs in the M group are further designated 1, 2, and 3. Tabs in the L and R groups are further designated 1.5 and 2.5.
In embodiments of the present invention in which improvement in tooth shade is assessed based on the VITA TOOTHGUIDE 3-D MASTER® system, value is determined first, followed by chroma. Hue is determined last, by matching with shade tabs of the value and chroma already determined. In these embodiments, the phrase improvement in shade is assessed by a threestep process as described immediately below.
Using a light source with a color temperature corresponding to daylight light (from 4600K 6500K, more preferably from 5500Kto 6500K), lightness, chroma and hue are determined.
First, the lightness of a patient's tooth is determined by holding the shade guide (i.e., sample) directly in front of the tooth, at a distance of approximately 25 - 30 cm. The trained observer (e.g., clinician) assigns a value (lightness level) on a six-point scale of 0,1, 2, 3, 4 or 5, with 0 being light and 5 being dark. When selecting the lightness level, the observer begins by looking at the dark end (5) and moves toward the light end (0).
2019100469 02 May 2019
Next, the observer matches chroma (pale or saturated). The observer starts by removing a shade guide with the middle hue (M) from the selected lightness level. The observer then chooses one of three chroma within the selected lightness level.
As a final step, the observer determines hue by comparing the selected shade guide to the shade guide directly to the left (L) and right (R), and determines whether the tooth is more yellow (L) or red (R) than the middle (M) shade guide.
The observer may, and in certain embodiments does, score chroma and hue using the 7-point plot shown in FIG. 5.
In preferred embodiments of the present invention the trained observer assigns an initial (baseline) shade based on the VITA TOOTHGUIDE 3-D MASTER® system, and then assigns a corresponding Shade Number ranging from 1 to 26. See FIG. 4. The observer then tracks improvement (lightening) of tooth shade based on reduction (lowering) of the shade number.
In particularly preferred embodiments, practicing the methods of the present invention produces an improvement in tooth shade by lowering shade number by at least three.
The following are non-limiting examples of what is meant by the phrase improvement in tooth shade by lowering shade number by at least three. A consumer starts with a shade number of 15 (3R2.5) and after administering one or a combination of oral care products of the present invention (e.g., a whitening dentifrice, and a whitening mouthwash; or a whitening dentifrice, a whitening mouthwash, and a whitening strip) the consumer's tooth shade number becomes 12 (3R1.5) or 11 (3L1.5) or 10 (3M1), preferably 9 (2M3), more preferably 8 (2R2.5) or 7 (2L2.5) or 6 (2M2), and even more preferably 5 (2R1.5) or 4 (2L1.5) or 3 (2M1). In the above example, a change from 15 to 12 represents an improvement of three (3) shade numbers, an improvement from 15 to 11 represents an improvement of four (4) shade numbers, an improvement from 15 to 10 represents an improvement of five (5) shade numbers, etc. Improvements of three, four, five, six, and seven shades lighter are summarized in Figures 6-10.
2019100469 02 May 2019
The VITA TOOTHGUIDE 3-D MASTER® is further described in the following scientific and patent publications, which are incorporated, in pertinent part, by reference: AJ Hasell et al., Determination of VITA Classical shades with the 3D-Master shade guide, Acta Odontol. Scand. Vol. 71, No. 3-4, pp. 721-726 (2014); N. Corcordel, et al, The linear shade guide design of Vita 3D-master performs as well as the original design of the Vita 3D-master, J. Oral Rehabil., Vol. 37, pp. 860-865 (2010); US Patent Application Pre-Grant Publication 2010/005563.
Other tooth shade guides are known to the person having ordinary skill in the dental arts and can be used to assess lightening achieved by practicing the methods of the present invention. Non-limiting examples of shade guide systems include: VITA Classical (VITA North America, Yorba Linda, California) and CHROMASCOP® (Ivoclar Vivadent, Inc., Amherst, NY).
The VITA CLASSICAL A1-D4® system is arranged by four hues - A, B, C, or D, and subdivided as follows: Al, A2, A3, A4 - reddish to brownish; Bl, B2, B3, B4 - reddish to yellowish; Cl, C2, C3, C4 - greyish; D2, D3, D4 - reddish to greyish.
The CHROMASCOP® system is arranged by value levels covering the area of the CIE 1976 (L*a*b*) color space of natural teeth. Five groups - ranging from white, yellow, light brown, grey, to dark brown - have tabs representing different chroma and hue.
In the CIE 1976 (L*a*b*) system, L* value represents comparative lightness / darkness (lower L* being indicative of darker), and a* and b* values represent chromaticity coordinates (red-green and blue-yellow, respectively). See A.R. Robertson, The CIE 1976 color-difference formulae, Color Res. Appl. Vol. 2, pp. 7-11 (1977). Each of the L*, a* and b* can be plotted in three-dimensional space to characterize a color in absolute terms. The magnitude of the difference between two colors, as perceived by the human eye, is proportional to the distance between two points defining the two colors on the three-dimensional plot. The difference between the two colors, the Euclidean distance (ΔΕ), is defined by the following equation: AE*ab = [(AL*)2 + (Aa*)2 + (Ab*)2]1/2. An increase in b* indicates tooth color is trending towards yellow; a decrease in b* means the color is trending towards blue.
Clinical Testing Examples
2019100469 02 May 2019
The examples that follow illustrate the practice ofthe present invention in some of its embodiments, but should not be construed as limiting the scope of the invention. Other embodiments will be apparent to one skilled in the art from consideration of the specification and examples. It is intended that the specification, including the examples, is considered exemplary only without limiting the scope and spirit of the invention.
Some of the examples illustrate preferred embodiments of the invention. Variations of these preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, unless otherwise indicated herein or otherwise clearly contradicted by context, the inventions include all modifications and equivalents ofthe subject matter disclosed and recited in the claims appended hereto as permitted by applicable law.
Twenty previously-extracted (20) teeth, classified as healthy by an experienced dentist using a loupe and headlamp, were selected and sterilized. By healthy is meant the teeth did not have any dental restorations or exhibit structural damage (e.g., pitting, enamel decay).
Two chips (i.e., a pair) were created from each tooth. Each chip had an approximate size of 5 mm x 5 mm x 3 mm in size. An impermeable plastic was affixed to the cut surfaces of the chips. Each pair was stained in a separate vial by immersion in a concentrated black tea solution overnight (for about 12 hours). The concentrated black tea solution was produced by steeping 2 teabags (LIPTON'S® yellow label black tea) in 1/2 cup of boiling water for 30 minutes. After staining, two (2) groups - Group 1 and Group 2 - were created. Each group consisted of ten pairs - A and B.
Chips in Group 1 were used to compare whitening of stained dental enamel by (i) a whitening mouthwash ofthe invention (Test Mouthwash) versus (ii) a commercial whitening mouthwash, CREST® 3D Whitening Mouthwash (Prior Art Mouthwash). As detailed below, Test Mouthwash achieved a similar degree of whitening as the Prior Art Mouthwash (no statistical difference, p>0.05).
2019100469 02 May 2019
Chips in Group 2 were used to compare whitening of stained dental enamel by (i) a whitening strip of the invention (Test Strips) versus (ii) a commercial whitening strip, CREST® 3D Whitening Strips (Prior Art Strips). As detailed below, Test Strips achieved a similar degree of whitening as Prior Art Strips (no statistical difference, p>0.05).
Effect of Whitening Strips of the Invention on Dental Enamel
Chips in Group 1A were treated with Test Strips. Chips in Group IB were treated with Prior Art Strips. By treated is meant a whitening strip was applied to the chip for 60 minutes; thereafter, the chips were immersed in a saliva solution for approximately one (1) minute. The saliva solution was collected fresh, without stimulation, and was filtered to remove particulate matter. The above procedure was repeated a total often (10) times.
At baseline (after staining but prior to the first treatment), and after each treatment (as defined below), L* and b* values were recorded using a reflectance spectrophotometer colorimeter (PCE-CSM 1, PCE Instrumentation, Alicante, Spain). Chips were photographed individually under standardized lighting conditions at each study time point.
Treatment with the Test Strip whitened the enamel surface of the chips, but had no visible effect on the underlying dentin. Mean standard deviation of L* was 9%. With the exception of T=8 hours (when b* for Test Strips was higher, and therefore, better than Prior Art Strips) differences in b* were not statistically significantly (p>0.05). (Because the difference at T=8 hours barely exceeded the mean standard deviation, this data point was viewed as a minor outlier.)
Effect of Whitening Mouthwash of the Invention on Dental Enamel
Chips in Group 2A were treated with a Test Mouthwash. Chips in Group 2B were treated with Prior Art Mouthwash. By treated is meant immersion for about one minute in either the Test Mouthwash or the Prior Art Mouthwash; thereafter, the chips were immersed in a fresh saliva solution as described above for approximately one (1) minute. The above procedure was repeated a total often (10) times. Each treatment (i.e., immersion) with a mouthwash is viewed as the clinical equivalent of use for thirty (30) consecutive days at the recommended
2019100469 02 May 2019 dose administered (rinsed) twice daily, each administration having a duration of 1 minute.
Colorimetry and clinical photographs were taken at the following time points: baseline (T=0), and the following seven time points post-immersion: 1 hour; 2 hours; 3 hours; 6 hours;
hours; 24 hours; 48 hours. Chips were photographed individually under standardized lighting conditions at each study time point.
Baseline b* values for the 2 groups did not differ significantly (p>0.05). Except as noted below, there were no statistically significant differences (p>0.05) between the effects of treatment with the Test and Prior Art Mouthwash formulations. At 6 hours, chips treated with the Prior Art Mouthwash showed a somewhat greater shift to a yellow hue. At 48 hours, chips treated with the Test Mouthwash showed a somewhat more yellow hue.
Baseline L* values for Groups 2A and 2B did not differ significantly (p>0.05). The efficacy of the Test Mouthwash and the Prior Art Mouthwash in terms of lightening did not differ significantly over the first three hours (p>0.05). The maximum effectiveness of the Test Mouthwash was observed after about 1 hour of treatment. Increased treatment time was observed to add approximately 6% of additional lightening effect.
Effect of Whitening Strips of the Invention on Dental Restorations
Dental restorations from fourteen (14) different manufacturers/suppliers - six (6) constructed from porcelain and eight (8) from composite materials - were used to prepare chips having an approximate dimension 3mm x 2mm x 1mm. 30 chips from the same supplier were mounted on three handling strips, each handling strip consisting of ten chips. All chips were stained by immersion in a concentrated black tea solution produced by steeping 2 teabags (LIPTON's® yellow label black tea) in % cup of boiling water for 2 hours.
One handling strip served as a control, and was stored in water at temperature of 4I21C and 100% humidity, and protected from ambient light in a sealed and labeled double-walled container. The remaining two handling strips (also referred to below as active intervention) underwent treatment, i.e., application of either a Test Strip or a Prior Art Strip to the chips for 60 minutes and, thereafter, immersion in a saliva solution (as described above in Example 1) for
2019100469 02 May 2019 approximately one (1) minute. Prior to treatment, the active intervention handling strips were stored in a 0.5% chloramine-T solution for 48 hours prior to start of the study.
At baseline (time = 0) and the following seven (7) specific time points, each measured from baseline, the surface structure of each sample was examined by light microscopy [Olympus® Cap Optical SZX Light Microscope (Center Valley, Pennsylvania), at 35x magnification] to determine changes in the chip surface, and specifically to identify cracking, pitting, dissolution, roughening or erosion: 1 hour, 3 hours, 6 hours, 9 hours, 12 hours, 18 hours, 24 hours. No visible surface damage was observed in any of the samples.
In addition, the color of each chip was measured by reflectance spectrophotometer (PCE-CSM 1, PCE Instrumentation (Alicante, Spain) D-65 standard illuminant; 4 mm diameter measuring area) and photographed under standard lighting conditions (i.e., the same lighting conditions were used throughout the study).
Color changes (e.g., lightening) were observed in both the Test Strips and Prior Art Strips, with no statistically significant difference between the groups; there was no difference between the control and the test groups at any time point, based on two-way ANOVA followed by Bonferroni post-test P > 0.05.
Effect of Whitening Strip of Invention on Surface of Porcelain and Composite Materials
Surface changes in dental restorations after use of Test Strips and Prior Art Strips were examined by Light Microscopy, Scanning Electron Microscopy (SEM), and Profilometry.
126 chips from the control and treatment groups were examined for surface damage - cracks, pits or fissures - under light microscopy (Olympus® Cap Optical SZX Light Microscope) at three different magnifications: lOx, 25x and 35x. No surface damage was observed in either the treatment groups (when compared to the controls) regardless of color, material and exposure duration.
Approximately half of the active intervention chips, and an equal amount of control chips, were affixed to Aluminum specimen mount disks using colloidal silver liquid (Ted Pella, Inc., Redding,
2019100469 02 May 2019
CA) and coated with 9.31 nm thick gold alloy. Samples were photographed using a Scanning
Electron Microscope (SEM) [FEI Magellan 400L FE-SEM, Nanolab Technologies, Inc. (Milpitas,
CA)] at three (3) magnifications (500x, lOOOx and 3000x).
Chips in treatment and control groups were compared to determine the extent of microstructural surface (if any) by a blinded evaluator with experience and training in evaluating enamel and dental restorations using SEM. The chips were scored as mild, moderate or severe. Mild: small, individual, non-connected minor pitting or roughening covering less than 10% of the sample surface. Moderate: individual or connected pitting or roughening covering less than 25% of the sample surface. Severe: widespread pitting or roughness covering more than 25% of the sample surface. At magnifications of from 500x to 3,000x, greater surface roughening was consistently observed in composite and porcelain chips treated with Prior Art Strips than those treated with Test Strips.
The remaining half of the active intervention chips, and an equal amount of control chips, were examined by profilometry (Perthometer M2, Mahr GmbH; Gottingen, Germany) with the following specifications and calibration: profilometer tip diameter = 2.4 mm; accuracy = 0.5 mm/sec; measuring path = 5.5 mm; cutoff value = 250 pm). Five measurements were taken for each chip sample. Average surface roughness (based on five measurements) was recorded and evaluated by repeated measures of variance technique (a= 0.05); coincidences were eliminated by Duncan test. After every seventh specimen (total of 35 measurements), the profilometer was recalibrated. Based on profilometry, significant increases in post-whitening roughness (ANOVA, P > 0.05) were observed in composite chips treated with Prior Art Strips, but not in composite chips treated with Test Strips. No significant increases in post-whitening roughness (ANOVA, P > 0.05) were observed in porcelain chips treated with Test Strips and Prior Art Strips.
Tooth Shade Lightening Effects of Whitening Strip of Invention
Five extracted teeth samples (numbered 1-5) with matching degrees of staining were selected. Tooth color was measured by an experienced, blinded, trained observer using standard colorimetry and the VITA TOOTHGUIDE 3D MASTER® tooth shade grading system. Lighting was indirect and standardized and all measurements were repeated three times.
2019100469 02 May 2019
At baseline, samples 1-3 had a shade of 3M2; samples 4 and 5 had a baseline shade of 2M1. Mean L* was 69.66; mean b* was 13.35. A whitening strip of the invention was administered to each sample for ten hours - representative of 20 treatments, each lasting 30 minutes. Samples 1-3 lightened to shade 1M1. Samples 4 and 5 also lightened to shade 1M1. After treatment, mean L* was 79.84; mean b* was 11.85.
Tooth Shade Lightening Effects of Whitening Mouthwash of Invention
Five extracted teeth samples (numbered 1-5) with matching degrees of staining were selected. Tooth color was measured by an experienced, blinded, trained observer using standard colorimetry and the VITA TOOTHGUIDE 3D MASTER® tooth shade grading system. Lighting was indirect and standardized and all measurements were repeated three times.
At baseline, samples 1-3 had a shade of 4M1; samples 4 and 5 had a baseline shade of 3M2. Mean L* was 68.99; mean b* was 11.17. Samples were treated by immersion in a whitening mouthwash of the invention for 48 hours. Samples 1-3 lightened to shade 3M1. Samples 4 and 5 also lightened to shade 3M1. After treatment, mean L* was 71.30; mean b* was 10.10.
In vivo Effects of Whitening Strip of Invention on Tooth Sensitivity and Gingival Irritation
Ten participants ages 18-45 (mean 29.4 years) - each with (i) a minimum of 16 clinically and radiographically healthy teeth, as determined by clinical examination and (ii) an absence of any pathological symptoms, gingival recession or tooth sensitivity prior to enrollment - were recruited to participate in a 10-day, randomized, double-blinded, clinical study.
At the commencement of the study, each subject received forty (40) identically packaged, coded whitening strips - 20 Test Strips (as defined above) and 20 Prior Art Strips (as defined above) - as well as a new soft-bristled Oral B® toothbrush and CREST Total Care® toothpaste. Subjects brushed their teeth twice daily and used only the oral hygiene products as described above. For example, no mouthwash or floss was used. Subjects applied four whitening strips - one on each designated quadrant of the mouth (i.e., upper left, lower left, upper right, lower right) - to the outer surface of the teeth for thirty (30) minutes each day. After treatment, subjects rinsed their mouths with water. After each application, on a daily basis, subjects
2019100469 02 May 2019 completed a questionnaire with respect to (a) tooth sensitivity and (b) gingival irritation. More particularly, subjects self-reported sensitivity using a 5-point Likert Scale and gingival irritation as yes or no). On Days 5 and 10 of the study, a blinded clinician evaluated (a) gingival irritation by visual inspection on a scale ranging from 0 to 3 and (b) sensitivity after a 3-second blast of pressurized air - (yes or no). Lower levels of gingival irritation were reported in the group that used Test Strips. Comparable levels of sensitivity were reported in users of the Test Strips and the Prior Art Strips, both as self-reported by questionnaire and as evaluated by clinical evaluation at on Days 5 and 10.
Stain Prevention by Whitening Pen of Invention
The effects of a whitening gel of the invention (Whitening Composition in Gel Carrier) administered by a pen applicator on enamel stain development during timed exposure to coffee and red wine were studied. As detailed below, in comparison to uncoated teeth, application (i.e., coating) teeth with the whitening gel of the present invention prevented enamel staining (darkening as measured in terms of changes in L*) for an additional 10 minutes of coffee exposure and an additional 20 minutes of red wine exposure.
Test Sample Preparation: 20 extracted teeth that appeared healthy to the naked eye and inspection under the light microscope (xlO) were bisected into 20 pairs. Standardized photography and colorimetry measurements were taken at baseline. One-half of each tooth was treated with two coats of the whitening gel of the present invention; the remaining half tooth was uncoated. On the treatment side, a first coat was administered (e.g., painted). After drying for 30 seconds, a second coat was applied. Sample pairs were immersed in individual 20mL aliquots of freshly brewed VIA® INSTANT coffee (Starbucks Corp., Seattle, Washington) according to the instructions on the packet (i.e., about one 3.3-gram packet add to 8 fluid ounces of hot water). The remaining 10 sample pairs were immersed in individual 20mL aliquots of red wine (CHARLES SHAW® Cabernet Sauvignon, Trader Joe's Company, Monrovia, California). Standardized photography and colorimetry to determine L* and b* values were repeated five times - every 10 minutes, for a total of 50 minutes.
2019100469 02 May 2019
Coffee staining: Coffee exposure of non-coated and coated teeth exhibited significant decrease in the L* value (darkening) over time. Teeth coated with whitening gel of the present invention began to exhibit staining after 30 minutes of immersion in coffee. In contrast, non-coated teeth began to exhibit staining after 20 minutes of coffee immersion. Changes in L* values were assessed by one-way ANOVA, as well as ANOVA with post hoc Tukey test. Minimal and not significant staining was observed at 10-minute and 20-minute time points (P>0.01). Compared to baseline, L* increased significantly for non-coated teeth at 20-, 30-, 40-, and 50-minute time points; respectively: P < 0.01, P < 0.01, P < 0.001, P < 0.001. For teeth coated with whitening gel of the present invention, significant L* increases (versus baseline) were observed at 30-, 40-, and 50-minute time points, but these changes were less significant than non-treated teeth; respectively, P < 0.05, P < 0.01, P < 0.01.
Red wine staining: Immersion of non-coated teeth resulted in a significant decrease of L* values after each of five time points (i.e, 10 minutes, 20 minutes, 30 minutes, 40 minutes, 50 minutes; respectively: P < 0.01, P < 0.01, P < 0.01, P < 0.001, P < 0.001; one-way ANOVA followed by Tukey post-test). Teeth coated with whitening gel of the present invention began to darken significantly only after being immersed in red wine for 30 minutes, with progressive darkening at each subsequent time point. Using one-way ANOVA followed by Tukey post-test, L* values were assessed at 0, 10, 20, 30, 40 and 50 minutes, respectively: P>0.01, P>0.01, P<0.01, P<0.01, P<0.01.
For both the coated and non-coated, groups, immersion in neither coffee nor red wine for up to 50 minutes caused a significant decrease in b* at any time point (P> 0.05 for all time points; two-way ANOVA.)
Teething Lightening/Brightening by Whitening Pen of Invention
The effects of a whitening gel of the invention (Whitening Composition in a Gel Carrier) were compared to a prior art carbamide peroxide whitening gel (AURAGLOW® Teeth Whitening Pen,
35% carbamide peroxide available from AuraGlow, LLC, Stamford, CT), both administered by a pen applicator.
2019100469 02 May 2019
Twenty extracted teeth that appeared healthy to the naked eye and after inspection under a light microscope (lOx) were bisected. Standardized photography and colorimetry measurements were taken at baseline. One-half of each tooth was coated two times with the whitening gel of the present invention; the remaining half of each tooth was likewise coated two times with the prior art carbamide peroxide gel of the present invention. A first coat was applied by a pen applicator and allowed to dry for about 30 seconds; a second coat was then applied.
Based on two-way ANOVA, statistically significant increases in L* values - indicative of teeth lightening - were observed in a time-dependent manner for both the whitening gel pen of the invention and the prior art carbamide peroxide whitening peroxide pen: treatment effect: P < 0.001; time effect: P < 0.0001). The whitening gel of the present invention lightened the tooth more quickly, with the first significant increase in L* values after 30 minutes of exposure (P < 0.05, P < 0.05, P < 0.01, P < 0.001, P < 0.001 for progressive time points vs baseline, one way ANOVA followed byTukey post-test). The carbamide peroxide gel produced a significant increase in L* values at 60 minutes (P > 0.05, P < 0.05, P < 0.01, P < 0.001, P < 0.001 for progressive time points vs baseline, one way ANOVA followed by Tukey post-test).
Case Study
A 65-year-old female patient presents with severe gum recession and enamel erosion, causing root as well as tooth sensitivity. The patient has badly-stained teeth attributable to consumption of coffee (about 2-3 cups per day). Consequently, the patient experiences short, sharp pain in response to thermal, tactile and/or chemical stimuli - collectively a condition known as dentinal hypersensitivity. See GR Holland et al., Guidelines for the design and conduct of clinical trials on dentine hypersensitivity. J Clin. Periodontol. Vol, 24, pp. 808-13 (1997). Dentinal sensitivity is assessed clinically by a jet of air and with an exploratory probe on the exposed dentin, in a mesio-distal direction, examining all the teeth in the area in which the patient complained of pain. The patient has been unable to tolerate in-office or at-home whitening treatments, including peroxide-based mouthwashes and toothpastes. The extent of pain from the peroxide whitening treatment is described as intolerable. The patient is able to
2019100469 02 May 2019 use the whitening strips of the present invention on a once-daily basis (thirty minutes per day) for twenty-eight consecutive days without experiencing sensitivity. Throughout the 28-day treatment period, the patient continues to consume coffee (2-3 cups/day). Surprisingly, a visible whitening of the patient's teeth of seven (7) shades on the VITA TOOTHGUIDE 3D MASTER® tooth shade grading system is observed.
Claims (5)
- What is claimed is:1. A method of visibly whitening tooth enamel by at least three shades as measured using the VITA TOOTHGUIDE 3D MASTER® tooth shade grading system comprising the step of administering to tooth enamel or a dental restoration an oral care product comprised of (a) Dead Sea salt, at a concentration of from about 0.5% to about 3.0%; and (b) a whitening complex consisting of two or three essential oils selected from the group consisting of (i) lemon peel oil, (ii) coconut oil, and (iii) sage oil.
- 2. The method of claim 1 wherein the oral care product is a dentifrice or a mouthwash that is administered for at least 30 seconds at least one time daily, and the oral care product is further comprised of (c) xylitol, (d) aloe vera leaf juice, and, optionally, (e) at least one essential oil selected from the group of peppermint oil, Wintergreen oil, and spearmint oil.
- 3. The method of claim 1 wherein the oral care product is a whitening strip that is conformable to the surfaces of the teeth and to the interstitial spaces between teeth, without permanent deformation thereof, and the oral care product is further comprised of at least one gelling agent selected from the group of Carbomer, carboxymethyl cellulose, carboxypropyl cellulose, poloxamer, carrageenan, magnesium aluminum silicate, carboxyvinyl polymers, and natural gums such as gum karaya, xanthan gum, guar gum, gum arabic, gum tragacanth, and mixtures thereof.
- 4. The method of claim 3 wherein the oral care product is a whitening strip that is removably affixed to the surfaces of the teeth and to the interstitial spaces between for a period of time from about 15 minutes to about 30 minutes
- 5. A method of reducing staining or discoloration of teeth or a dental restoration caused by (a) ingesting consumable chromogenic substance selected from the group consisting of coffee, tea, red wine, berries, soy sauce, curry, or smokeless tobacco or (b) smoking a cigarette, wherein prior to ingesting a consumable chromogenic substance or smoking a cigarette, a person applies one or two coats of whitening gel to the outer surface of the teeth, where each coat is from about 0.25 ml to about 0.5 ml, and the whitening gel is comprised of a tooth whitening complex consisting essentially of (a) a sea salt and (b) at least two essential oils selected from the group consisting of (i) lemon peel oil; (ii) coconut oil; and (iii) sage oil.2019100469 02 May 2019
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2019100469A AU2019100469A4 (en) | 2019-05-02 | 2019-05-02 | Methods and compositions for visibly whitening teeth without peroxide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2019100469A AU2019100469A4 (en) | 2019-05-02 | 2019-05-02 | Methods and compositions for visibly whitening teeth without peroxide |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2019100469A4 true AU2019100469A4 (en) | 2019-06-06 |
Family
ID=66674240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2019100469A Ceased AU2019100469A4 (en) | 2019-05-02 | 2019-05-02 | Methods and compositions for visibly whitening teeth without peroxide |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2019100469A4 (en) |
-
2019
- 2019-05-02 AU AU2019100469A patent/AU2019100469A4/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Davies et al. | Dentifrices-an update | |
JP3945703B2 (en) | System for delivering cosmetic and / or therapeutically active substances to the oral surface using an integrated carrier | |
US9724541B2 (en) | Dental cleaning and polishing composition comprising diamond particles | |
KR20070042192A (en) | Oral care composition comprising essential oils | |
US20070254067A1 (en) | Consumer customizable oral care products | |
Al Habashneh et al. | The effect of a triclosan/copolymer/fluoride toothpaste on plaque formation, gingivitis, and dentin hypersensitivity: A single-blinded randomized clinical study | |
US20070292364A1 (en) | Method for measurably improving oral health | |
CN111000772A (en) | New use of exocarpium Citri Grandis extract | |
EP1663138B1 (en) | Dye composition and method for detection of demineralized lesions in teeth | |
US20230000738A1 (en) | Oral Care Compositions and Methods | |
RU2457829C2 (en) | Mineral and vitamin complex for strengthening tooth enamel, composition for oral cavity hygiene and toothpaste | |
US20210015734A1 (en) | Oral Care Products and Methods | |
Singh et al. | A clinical investigation of the efficacy of three commercially available dentifrices for controlling established gingivitis and supragingival plaque | |
US20180360732A1 (en) | Oral Care Products and Methods | |
AU2019100469A4 (en) | Methods and compositions for visibly whitening teeth without peroxide | |
CN105377865B (en) | Oral care composition containing desoxysugar antimetabolite | |
Yigit et al. | Antifungal activity of toothpastes against oral Candida isolates | |
EP3984521A1 (en) | Oral care article comprising a hydrophobic delivery carrier and solid hydrophilic particles comprising a bleaching agent | |
US8871183B2 (en) | Composition for promoting and maintaining oral health | |
EP3737351A1 (en) | Oral care products and methods | |
AU2019100471A4 (en) | Methods and compositions for reducing tooth, root and dentin sensitivity | |
WO2011161240A2 (en) | Tooth whitening composition and method | |
AU2019100472A4 (en) | Methods and compositions for treating gingivitis and inflammation and reducing plaque and tartar | |
Pader | Dental products | |
US20180360735A1 (en) | Oral Care Products and Methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |